Percutaneous Coronary Angioplasty Compared With Exercise Training in Symptomatic Coronary Artery Disease
NCT ID: NCT00176358
Last Updated: 2007-09-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2/PHASE3
400 participants
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PTCA and Stent Implantation
Exercise Training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stable coronary artery disease
* Eligible patients could be asymptomatic or have class I to III angina (Canadian Cardiovascular Society \[CCS\]) with documented myocardial ischemia
* Angina pectoris threshold \> 50 Watt (cycle ergometry)
* Permanent residence should be within 25 km of training facility.
Exclusion Criteria
* Patient currently participating in an exercise training program
* Unstable angina pectoris or myocardial infarction during the last 2 weeks
* Symptoms of CCS class IV
* Exercise limitations due to clinical conditions not related to CAD
* Left ventricular ejection fraction (LVEF) of \< 40%
* Ventricular arrhythmia (Lown Ivb)
* Hemodynamically significant valvular heart disease
* Previous cardiac surgery
* PTCA performed during the last 12 months
* Any major non-cardiac condition that would adversely affect survival during the duration of the study
* Reduced compliance
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Leipzig
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rainer Hambrecht, Prof.
Role: PRINCIPAL_INVESTIGATOR
Heart Center Leipzig - University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Leipzig - Heart Center
Leipzig, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Sven Möbius-Winkler, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
139/2001
Identifier Type: -
Identifier Source: org_study_id